Market Capitalization (Millions $) |
20 |
Shares
Outstanding (Millions) |
48 |
Employees |
116 |
Revenues (TTM) (Millions $) |
11 |
Net Income (TTM) (Millions $) |
-82 |
Cash Flow (TTM) (Millions $) |
-85 |
Capital Exp. (TTM) (Millions $) |
0 |
Bioatla Inc
Bioatla Inc is a biotechnology company that focuses on developing antibody-based therapeutics for the treatment of cancer and other diseases. The company utilizes its proprietary Bioaccelerator' platform, which enables the discovery and optimization of therapeutic antibodies with enhanced selectivity and potency. Bioatla's approach combines bioinformatics, protein engineering, and cell biology to create targeted therapies that have the potential to improve patient outcomes. The company's pipeline includes multiple novel antibody candidates in various stages of development, addressing different cancer types and other indications. Bioatla Inc is dedicated to advancing precision medicine through its innovative antibody-based approach to therapy.
Company Address: 11085 Torreyana Road San Diego 92121 CA
Company Phone Number: 558-0708 Stock Exchange / Ticker: NASDAQ BCAB
|